3-(alpha-D-Galactopyranosyloxy)-5-nitrobenzamide

**3-(alpha-D-Galactopyranosyloxy)-5-nitrobenzamide** is an experimental small molecule belonging to the class of phenolic glycosides, characterized by a benzamide core substituted with a nitro group and an alpha-linked D-galactopyranoside moiety. It has not been approved for any therapeutic use and is not currently in clinical trials. The compound's structure suggests potential utility as a glycoside drug precursor or intermediate, possibly for the synthesis of aminoglycoside antibiotics or other biologically active glycosides. Glycosylation modifications like those present in this molecule are often used to improve solubility, metabolic stability, and biological targeting of drugs; such compounds may be explored for antiviral, antibacterial, anticancer, or immunomodulatory applications[1][6][7]. However, there_is no evidence that this specific compound has reached clinical development or approval.

Other names

3-(α-D-Galactopyranosyloxy)-5-nitrobenzamide5-aminocarbonyl-3-nitrophenyl-alpha-D-galactopyranose